Prehospital Recognition and Identification of Unspecific Symptoms

Karolinska Institutet414 enrolled

Overview

This study evaluates the predictive value of soluvent urokinase plasminogen activator receptor (suPAR) and lactate with respect to serious conditions among patients presenting to the EMS with unspecific symptoms.

Study Type

OBSERVATIONAL

Enrollment

414

Conditions

Serious Condition Morality

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Unspecific symptoms (not feeling well, decreased general health condition, unable to cope with usual daily activities, feeling weak) * Normal vital signs * Transported to ED * Able to give informed consent/ Next of kin gives informed consent Exclusion Criteria: * Specific symptoms * under 18 years of age * Stays home / other caregiver than ED * Referral from caregiver * No personal numer (social security number)

Locations (2)

Helsinki University

Helsinki, Finland

Karolinska Institute

Stockholm, Sweden

Outcomes

Primary Outcomes

Serious condition

Predefined serious condition

Time frame: During medical care event

Secondary Outcomes

Mortality

24h and 30 day mortality

Time frame: 24hours and 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.